Unique Discovery Aspects of Utilizing Botanical Sources

A Practical Guide to Assay Development and High-Throughput Screening in Drug Discovery

Volumn , Issue , 2009, Pages 213-232

  Manly, Susan P ^a   Smillie, Troy ^a   Hester, John P ^a   Khan, Ikhlas ^a   Coudurier, Louis ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b Clewell 21st Century Tox Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85179287986     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420070514-18     Document Type: Chapter

References (53)

1. Appleton, D.R., Buss, A.D., and Butler, M.S. 2007. A simple method for high-throughput extract prefractionation for biological screening. Nat. Prod. Drug Disc. 61, 327-331.
2. Bazin, H., Trinquet, E., and Mathis, G. 2002 Time resolved amplification of cryptate emission: A versatile technology to trace biomolecular interactions. J. Biotechnol. 82, 233-250.
3. Bouley, J. 2007 A natural fit. Drug Disc. News, Internet version.
4. Busse, W. 1999. The processing of botanicals. In Eskinazi, D.P. (Ed.). Botanical Medicine: Efficacy, Quality Assurance and Regulation. Larchmont, NY: Mary Ann Liebert, pp. 143-145.
5. Carter, G.T. 1998. LC/MS and MS/MS procedures to facilitate dereplication and structure determination of natural products. In Natural Products Drug Discovery II: New Technologies to Increase Efficiency and Speed. Sapienza, D.M. and Savage, L.M., Eds. Southborough, MA: IBC Communications, pp. 3-19.
6. Chen, S.T. et al. 2008. New therapies from old medicines. Nat. Biotechnol. 26, 1077-1083.
7. Dev, S. 1997. Ethnotherapeutics and modern drug development: the potential of Ayurveda. Curr. Sci. 73, 909-928.
8. Dev, S. 1999. Ancient-modern concordance in Ayurvedic plants: some examples. Environ. Health Persp. 107, 783-789.
9. Eisenberg, D.M. et al. 1998. Trends of alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280, 1569-1575.
10. Feng, B.Y. et al. 2005. High-throughput assays for promiscuous inhibitors. Nat. Chem. Biol. 1, 146-148.
11. Flaster, T. 1999. Shipping, handling, receipt, and short-term storage of raw plant materials. In Eskinazi, D. et al., Eds. Botanical Medicine: Efficacy, Quality Assurance and Regulation. Larchmont, NY: Mary Ann Liebert, pp. 139-142.
12. Harvey, A. 2000. Strategies for discovering drugs from previously unexplored natural products. Drug Disc. Today 5, 294-300.
13. Hoffman, F.A. and Garvey, T., IV. Textbook of Legal Medicine, 5th ed. 2001.
14. Kahn, I.A. 2006. Issues related to botanicals. Life Sci. 78(18): 2033-2038.
15. Kolb, J.M. and Manly, S.P. 1997. Adaptation of time-resolved fluorescence to homogeneous screening formats. In Janzen, B., Ed. High-Throughput Screening: The Discovery of Bioactive Substances, New York: Marcel Dekker, pp. 377-388.
16. Kolb, J.M., Yamanaka, G.Y., and Manly, S.P. 1996. Use of novel homogeneous fluorescent technology in highthroughput screening. J. Biomol. Screen. 1, 203-210.
17. Kugawa, F., Watanabe, M., and Tamanoi, F. 2007. Chemical biology/chemical genetics/chemical genomics: importance of chemical library. Chem-Bio Inform. J. 7, 49-68.
18. Lang, G. et al. 2008. Evolving trends in the dereplication of natural product extracts: New methodology for rapid, small-scale investigation of natural product extracts. J. Nat. Prod. 71, 1595-1599.
19. Manly, S.P., Lowe, S., and Padmanabha, R. 2002. Natural products or not? How to screen for natural products in the emerging HTS paradigm. In Janzen, B., Ed. High-Throughput Screening: Methods and Protocols. Totowa, NJ: Humana Press, pp. 153-168.
20. Mathis, G. 1999. HTRF® technology. J. Biomol. Screen. 4, 309-313.
21. McChesney, J.D. 1999. Quality of botanical preparations: environmental issues and methodology for detecting environmental contaminants. In Eskinazi, D. et al., Eds. Botanical Medicine: Efficacy, Quality Assurance and Regulation. Larchmont, NY: Mary Ann Liebert, pp. 127-131.
22. McChesney, J.D., Venkataraman, S.K., and Henri, J.T. 2007. Plant natural products: back to the future or into extinction? Phytochemistry 68, 2015-2022.
23. Newman, D.J. and Cragg, G.M. 2007. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70, 461-477.
24. Padmanabha, R., Cook, L.S., and Manly, S.P. 1996. Use of equilibrium dialysis to estimate sizes of active materials in natural product extracts. J. Biomol. Screen. 13, 131-133.
25. Phillipson, J., Zhu, M., and Cai, Y. 1998. Biological testing of plant extracts: should polyphenols be removed? Polyphen. Act. 18, 22-25.
26. Pisano, G.P. 2006. Can science be a business? Harvard Bus. Rev. October, 114-125.
27. Reichling, J. and Saller, R. 1998. Quality control in the manufacturing of modern herbal remedies. Q. Rev. Nat. Med. Spring, 21-28.
28. Rouhi, A.M. 2003. Natural products redux Chem. Eng. News 81(41), 77-107.
29. Shanmugam, S., Manikandan, S., and Rajendran, K. 2009. Ethnomedicinal survey of medicinal plants used for treatment of diabetes and jaundice among villagers of Sivagangai District, Tamil Nadu. Ethnobot. Leaf. 13, 189-194.
30. Silva, G.L., Lee, I.S., and Kinghorn, A.D. 1998. Special problems with the extraction of plants. In Natural Products Isolation, Vol. 4, Methods in Biotechnology, Cannell, R.J.P., Ed. Totowa, NJ: Humana Press, pp. 343-363.
31. Simon, J.E. 1999. Domestication and production considerations in quality control of botanicals. In Eskinazi, D. et al., Eds. Botanical Medicine: Efficacy, Quality Assurance and Regulation. Larchmont, NY: Mary Ann Liebert, pp. 133-137.
32. Sutherland, I. et al. 1999. LITCHI: knowledge integrity testing for taxonomic databases. Eleventh International Scientific and Statistical Database Management Conference.
33. Van Middlesworth, F. and Cannell, R.J.P. 2008. Dereplication and partial identification of natural products. In Natural Products Isolation, Vol. 4, Methods in Biotechnology, Cannell, R.J.P., Ed. Totowa, NJ: Humana Press, pp. 279-327.
34. Wall, M.E. et al. 1996. Effects of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal. Phytomedicine 3, 281-285.
35. Medicinal plant use: http://www.siu.edu/~ebl/leaflets/juand9.htm
36. NIH Roadmap Initiative: http://nihroadmap.nih.gov/overview.asp
37. Companies selling collections of natural product compounds: http://www.rechemical.com/natural-compounds
38. Companies with unique platforms for natural products: WellGen: http://www.wellgen.com/products/php
39. Cetek: http://www.cetek.com/drug_disc_plat.html
40. AnalytiCon Discovery: www.ac-discovery.com
41. BioPlanta, www.bioplanta-leipzig.de
42. NCI Natural Products Repository: http://www.dtp.nci.nih.gov/branches/npb/repository.html
43. DSHEA: http://www.fda.gov/opacom/laws/dshea.html#sec3
44. GRAS notification: http://www.cfsan.fda.gov/~dms/opa-noti.html
45. Dietary supplement health claims guidance: http://www.cfsan.fda.gov/~dms/opa-noti.html
46. Botanical drug product guidance: www.fda.gov/cder/guidance
47. CDER: http://www.fda.gov/Cder/
48. To report safety-related adverse events for dietary supplements to FDA: www.SafetyCall.com
49. FDA’s Center for Food Safety and Applied Nutrition’s Adverse Event Reporting System (CAERS): http://www.fda.gov/opacom/backgrounders/problem.html
50. Good Manufacturing Practices and Good Agricultural Practices: http://www.ienica.net/policy/goodagpracherbs.htm
51. http://www.actahort.org/members/showpdf?booknrarnr=249_16
52. http://www.inaro.de/Deutsch/ROHSTOFF/industrie/HEILPFL/GAPengl.htm
53. http://whqlibdoc.who.int/publications/2003/9241546271.pdf